Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 275,000 | 288,000 | 265,000 | 258,000 | 268,000 |
| Cost of Goods | 27,000 | 25,000 | 19,000 | 28,000 | 25,000 |
| Gross Profit | 248,000 | 263,000 | 246,000 | 230,000 | 243,000 |
| Operating Expenses | 185,000 | 146,000 | 118,000 | 158,000 | 364,000 |
| Operating Income | 63,000 | 117,000 | 128,000 | 72,000 | -121,000 |
| Interest Expense | 11,000 | 16,000 | 12,000 | 13,000 | 12,000 |
| Other Income | 2,000 | 2,000 | 1,000 | 0 | 0 |
| Pre-tax Income | 54,000 | 103,000 | 117,000 | 59,000 | -133,000 |
| Income Tax | 4,000 | 30,000 | 37,000 | -18,000 | 16,000 |
| Net Income Continuous | 50,000 | 73,000 | 80,000 | 77,000 | -149,000 |
| Net Income | $50,000 | $73,000 | $80,000 | $77,000 | $-149,000 |
| EPS Basic Total Ops | 0.35 | 0.50 | 0.55 | 0.55 | -1.05 |
| EPS Basic Continuous Ops | 0.35 | 0.51 | 0.56 | 0.53 | -1.03 |
| EPS Diluted Total Ops | 0.35 | 0.50 | 0.55 | 0.50 | -1.00 |
| EPS Diluted Continuous Ops | 0.33 | 0.49 | 0.53 | 0.51 | -1.00 |
| EBITDA(a) | $68,000 | $119,000 | $130,000 | $74,000 | $-121,000 |